HIGHLIGHTS
- who: Tushar Garg MD from the The National Institutes of Health-funded studies had a higher enrollment of African American and American Indian or Native Alaskan participants. have published the article: Racial and Ethnic Disparities among Participants in Hepatocellular Carcinoma Clinical Studies Evaluating Transarterial Therapies, in the Journal: (JOURNAL) of January/29,/2022
- what: To assess the current state of racial and ethnic representation in the transarterial treatment trials for HCC, this study compared completed U.S.-based clinical trials with race and ethnicity data to the current U.S. population with HCC. The results . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.